3SOF

Quote from: traderjbr on September 17, 2007, 10:42:44 AM
Fresh news,macd, obv, breaking out here,stock staging a turnaround.

Quote from: traderjbr on September 13, 2007, 01:13:39 PM
Another pop today,may have to keep a watch this one..

Quote from: setravis on September 05, 2007, 10:35:02 PM
Resurrection for GNTA.......

Quote from: setravis on September 05, 2007, 04:35:17 AM
Buying here !
Stocks under $1.00...but too many times I have seen them reach $1.00 again !
Looks oversold, positive money flow increasing, MACD reversing, all looks good, shows good support at 0.80...Should go up without news, and surge on speculation of European approval

Looks to have found some good support @ the $1 area...
Where she took a nice bounce off the 13-day MA !
Now we have broke back above the 50-day MA...nice volume in this process.


52wk Range: 0.75 - 6.60
Volume: 2,101,579
Avg Vol (3m): 432,142

Technicals
Percentage Gainer

RS Rating: 99 

Fundamentals
Key Data:
Market Cap (M): $39.19 
P/E Ratio: 388.89 
PEG Ratio: N/A 
Next Earnings: 11/06/2007
Last Analyst Rating: Hold

AP
Movers Roundup: Rubbermaid, Genta
Monday September 17, 2:46 pm ET 
Movers Roundup: Newell Rubbermaid Up on Raised View, Genta Jumps on Drug Trial Launch


Among the stock activity stories for Monday, Sept. 17, from AP Financial News:
NEW YORK (AP) -- Shares of Newell Rubbermaid Inc. rose on Monday, after the home-products maker raised its guidance due to better-than-expected sales.


NEW YORK (AP) -- Shares of Genta Inc. rose sharply Monday after the biotechnology company said it started the first clinical trial of its oral drug to treat bone disease.

NEW YORK (AP) -- Shares of Business Objects SA rose in afternoon trading Monday, on market rumors that the business intelligence software maker is seeking to be bought out.

NEW YORK (AP) -- Shares of Morgans Hotel Group Co. slid Monday as an analyst downgraded the luxury hotel operator, citing a more cautious view of the lodging sector.

NEW YORK (AP) -- Shares of Las Vegas Sands Corp. surged to a fresh 52-week high Monday as two analysts lifted their price targets on continued optimism about the Venetian Macao Hotel Resort's success.

Seeing a nice spike in the price & volume today..

update:

Genta's Phase III melanoma study receives positive review from DMB
Tuesday , September 16, 2008 08:47ET

Sep 16, 2008 (Datamonitor via COMTEX) -- US-based biopharmaceutical company Genta has announced that the independent data monitoring board for Agenda, a Phase III trial of the company's lead oncology product Genasense injection, has completed its review.

During its review, the data monitoring board (DMB) evaluated safety data from the study and conducted an analysis for futility. With more than half of the initially planned number of patients now enrolled, the board recommended that the trial continue to completion of full enrollment.

Agenda is a Phase III, randomized, double-blind, placebo-controlled trial that is intended to support global registration of Genasense for patients with advanced melanoma.

The study is designed to confirm certain safety and efficacy results from Genta's prior randomized trial of Genasense combined with dacarbazine in patients identified by a biomarker who have not previously received chemotherapy. The co-primary endpoints of Agenda are progression-free survival and overall survival. A total of 300 patients are expected to enroll in Agenda.

Loretta Itri, president of pharmaceutical development at Genta, said: "We remain quite pleased with the high investigator enthusiasm for Agenda. We currently anticipate that accrual will complete in the first quarter of 2009."

Is now GNTA.OB
GNTA had a spike to $0.031 last week representing a gain of roughly 240% since 01/28/2009

Updated chart scene...

updated chart look...

Could turn into a gold mine...

GNTA.OB---Volume alert

52wk Range: 0.01 - 0.87
Volume: 1,006,291,262
Avg Vol (3m): 3,651,570

Technicals
Record Volume
Close Above the 50-day MA
Most Actives
Percentage Gainer

Last Price Quote is:
69.87%above 13-day MA
8.23%above 50-day MA
RS Rating: 21 

Fundamentals
Earnings Expected on May 12

Key Data:
Market Cap (M): $14.00 
P/E Ratio: 388.89 
PEG Ratio: N/A 
Next Earnings: 05/12/2009
Last Analyst Rating: Hold

GNTA - Momentum...
http://www.chartmoney.com/stockquotes.php?ticker=gnta
Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer.


Day's Range: 0.0610 - 0.0990
52wk Range: 0.02 - 650.00
Volume: 15,427,171
Avg Vol (3m): 2,534,480
Market Cap: 5.24M

Technicals
Last Price Quote is:
64.62%above 13-day EMA
34.41%above 50-day EMA
RS Rating: 99 

New Highs & Breaking out off Huge bottom...
this stock has some potential.